HOUSTON—Louisiana has reached a $20 million settlement of its lawsuit against pharmaceutical manufacturer Eli Lilly and Co. over off-label marketing of the antipsychotic drug Zyprexa, Louisiana Attorney General Buddy Caldwell (D) announced April 7 (In re Zyprexa Products Liability Litigation).
The lawsuit, filed under Louisiana’s Unfair and Deceptive Trade Practices Act, alleged that Eli Lilly engaged in unfair and deceptive practices when it promoted the off-label marketing of Zyprexa.
The settlement was filed March 31 in the U.S. District Court of the Eastern District of New York.
Louisiana was one of 13 states that individually sued Eli Lilly ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.